European Urological Device Market Snapshot
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH devices—especially Aquablation, and UI devices. Additional market drivers include rising obesity rates, premium device adoption, and broader access to less-invasive treatments. However, reimbursement challenges, litigation risks tied to genitourinary meshes, and healthcare budget constraints will limit uptake of newer, premium-priced technologies.
Read our Market Snapshot to access data and analysis on the market for urological devices in Europe from 2019 through 2034.